# Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee

> **NCT06228274** · — · COMPLETED · sponsor: **LCA Pharmaceutical** · enrollment: 218 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** ARTHRUM 2.5%

## Key facts

- **NCT ID:** NCT06228274
- **Lead sponsor:** LCA Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-09
- **Final completion:** 2017-03
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2024-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06228274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06228274, "Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06228274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*